Fever Tracking Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

61 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-07

Study Completion Date

2022-03-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate the feasibility of continuous fever tracking of participants having fever symptoms in a home setting, using a core body temperature (CBT) sensor. CBT as measured by the wearable sensors will be coampared with CBT as measured by ingestible electronc pills (reference).

A secondary research question is, if the CBT behavior of the the participants in a home setting can be compared to previously described CBT profiles in the literature, and if special patterns can be identified.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fever Algorithm Development of a Non-invasive Wearable Core Body Temperature Sensor System in Intensive Care Unit Patients

NCT04182945

Fever

TERMINATED NA

Principles and Test Methods of Non-contact Body Thermometry

NCT05247736

Thermometry

UNKNOWN

Comparison of a Novel Non-Invasive, Non-Touch Infrared Thermometer With Routine Thermometry in Routine Clinical Practice

NCT02805322

Healthy Febrile

COMPLETED PHASE4

Tympanic Thermometer Study

NCT06556628

Body Temperature Changes Fever

ACTIVE_NOT_RECRUITING

Quantifying and Understanding the Signs and Symptoms of Fever

NCT01287143

Fever

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Core Body Temperature in Healthy Subjects Immune Response to mRNA COVID-19 Vaccination

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-60 years old
* Informed consent signed
* Either:

Acute fever symptoms at inclusion (at least 38.0°C) and Test for COVID-19 at the day of inclusion

\- Or: Second shot or booster of mRNA COVD-19 vaccination (Comirnaty® or COVID-19 Vaccine Moderna®) at day of inclusion

Exclusion Criteria

* Any participant who, for any reason, is unable to independently consent to participate in the study and/or who is unable to independently follow the study protocol.
* Any participant with previous surgical procedures in the gastrointestinal tract
* Inability to swallow pills
* Any participant of ≤40 kg body weight
* A scheduled MRI examination in the period from the start of the measurements until seven days after ingestion of the electronic pill.
* Any participant being pregnant
* Impairment or disability of the upper extremity likely to have a negative impact on the quality of measurements:

* Wounds
* Active venous access
* Amputations
* Dialysis shunt
* Edema
* Axillary dissection
* Continuous long-term monitoring of blood pressure
* Tattoos
* Known allergy to plastics / latex
* Language problems

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes